Back to all studies
CompletedNCT00448630

An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics

This study is completed. It focuses on schizophrenia and currently lists study information in Turkey.

Schizophrenia, Metabolic Syndrome XObservationalFrom 18 Years to 55 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This observational study follows adults living with schizophrenia to understand their experience, outcomes, or changes over time.

What would participation involve?

Participants may receive METABOLIC SYNDROME PARAMETERS, attend study visits with the research team. The registry lists locations in Türkiye.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: October 23, 2007
Recruitment status
Completed
Enrollment listed in the registry
328
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Sponsor type
Other organization
Study type
Observational
Intervention type
OTHER
Study phase
Not clearly listed
Locations
Türkiye
Age range
From 18 Years to 55 Years
Official registry ID
NCT00448630
Official title
A MULTI-CENTER, NON-INVASIVE OBSERVATIONAL STUDY OF METABOLIC SYNDROME PARAMETERS IN SCHIZOPHRENIC PATIENTS USING ATYPICAL ANTIPSYCHOTICS

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT00448630. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Türkiye · 47 sites
  • Adana Psychiatry and Neurology Hospital
    Kurttepe, Adana
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Kurttepe, Adana
    Site status: Not listed — confirm with the team
  • Adana Psychiatry and Neurology Hospital
    Adana
    Site status: Not listed — confirm with the team
  • Cukurova University Scool of Medicine
    Adana
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Adana
    Site status: Not listed — confirm with the team
  • Ankara Oncology Research and Training Hospital
    Ankara
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Ankara
    Site status: Not listed — confirm with the team
  • Ankara Diskapi Training and Research Hospital
    Ankara
    Site status: Not listed — confirm with the team
  • Ankara Numune Research Hospital
    Ankara
    Site status: Not listed — confirm with the team
  • Ankara Numune Training and Research Hospital Department of Psychiatry
    Ankara
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Ankara
    Site status: Not listed — confirm with the team
  • Antakya Mustafa Kemal University School of Medicine
    Antakya
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Antakya
    Site status: Not listed — confirm with the team
  • Bolu Psychiatry and Neurology Hospital
    Bolu
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Bolu
    Site status: Not listed — confirm with the team
  • Pamukkale University School Of Medicine
    Denizli
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Denizli
    Site status: Not listed — confirm with the team
  • Elazig Mental Illness And Diseases Hospital
    Elâzığ
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Elâzığ
    Site status: Not listed — confirm with the team
  • Eskisehir Osmangazi University
    Eskişehir
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Eskişehir
    Site status: Not listed — confirm with the team
  • Bakirkoy Psychiatry and Neurology Hospital
    Istanbul
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Istanbul
    Site status: Not listed — confirm with the team
  • Bakirkoy Mental Health Hospital, First Clinic of Neurosis
    Istanbul
    Site status: Not listed — confirm with the team
  • Bakirkoy Psychiatry and Neurology Hospital
    Istanbul
    Site status: Not listed — confirm with the team
  • Cerrahpasa School of Medicine
    Istanbul
    Site status: Not listed — confirm with the team
  • Erenkoy Psychology and neurology hospital
    Istanbul
    Site status: Not listed — confirm with the team
  • Istanbul University Istanbul School of Medicine
    Istanbul
    Site status: Not listed — confirm with the team
  • Marmara School of Medicine
    Istanbul
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Istanbul
    Site status: Not listed — confirm with the team
  • Sisli Etfal Research and training Hospital
    Istanbul
    Site status: Not listed — confirm with the team
  • Vakif Gureba Hospital, Department of Psychiatry
    Istanbul
    Site status: Not listed — confirm with the team
  • Ege University School Of Medicine
    Izmir
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Izmir
    Site status: Not listed — confirm with the team
  • Kayseri Public Hospital
    Kayseri
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Kayseri
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Konya
    Site status: Not listed — confirm with the team
  • Selcuk University Medical School Department of Psychiatry
    Konya
    Site status: Not listed — confirm with the team
  • Manisa Mental Illness And Diseases Hospital
    Manisa
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Manisa
    Site status: Not listed — confirm with the team
  • 19 may University School of Medicine
    Samsun
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Samsun
    Site status: Not listed — confirm with the team
  • Samsun Mental Illness And Diseases Hospital
    Samsun
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Trabzon
    Site status: Not listed — confirm with the team
  • Trabzon Numune Research Hospital
    Trabzon
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Trakya
    Site status: Not listed — confirm with the team
  • Trakya University School of Medicine
    Trakya
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring observational follow-up for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Is this an interview, survey, or observational study?

This appears to be a interview / survey / observational study involving No intervention. Phase is mainly useful to check for medication studies and some device studies.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 18 Years to 55 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to answer questionnaires or take part in interviews. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Could the questions feel emotionally difficult or personal?

If the study involves interviews or questionnaires, some questions may feel personal or emotionally sensitive. Ask whether you can skip questions, pause, stop, and how your answers will be protected. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc., which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me